Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec:35:116-24.
doi: 10.1016/j.sbi.2015.11.005. Epub 2015 Nov 28.

Radical-mediated ring contraction in the biosynthesis of 7-deazapurines

Affiliations
Review

Radical-mediated ring contraction in the biosynthesis of 7-deazapurines

Vahe Bandarian et al. Curr Opin Struct Biol. 2015 Dec.

Abstract

Pyrrolopyrimidine containing natural products are widely distributed in Nature. The biosynthesis of the 7-deazapurine moiety that is common to all pyrrolopyrimidines entails multiple steps, one of which is a complex radical-mediated ring contraction reaction catalyzed by CDG synthase. Herein we review the biosynthetic pathways of deazapurines, focusing on the biochemical and structural insights into CDG synthase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Labeling patterns observed in the biosynthesis of folic acid and deazapurines. In both cases, C-2 (red sphere) of the starting purine is retained but C-8 (grey sphere) is lost. In addition, C-1’, C-2’, and C-3’ (blue spheres) of the proffered purine ribose become incorporated into the final product.
Figure 2
Figure 2
Core steps in the biosynthesis of 7-deazapurines are catalyzed by the successive actions of three enzymes.
Figure 3
Figure 3
Tailoring steps from CDG to (A) the hypermodified tRNA base queuosine and (B) the secondary metabolites toyocamycin and sangivamycin.
Figure 4
Figure 4
Activation of RS enzymes requires reduction of the [4Fe-4S] cluster to the +1 oxidation state. In vivo, NADPH is thought to supply the necessary reducing equivalents via Fpr/Fld (A). Once reduced, the RS cluster catalyzes the reductive cleavage of SAM to generate a dAdo•, which initiates catalysis by H-atom abstraction from the substrate (B).
Figure 5
Figure 5
Reductive activation of B. subtilis CDG synthase with Fld homologs from E. coli and B. subtilis. Both the biological reducing system NADPH/Fld/Fpr (A) and dithionite/Fld (B) are able to activate CDG synthase. Of the Fld homologs, YkuN is able to maintain activity of CDG synthase at significantly lower concentrations than YkuP or Fld.
Figure 6
Figure 6
Mechanism of CDG synthase. Radical-mediated ring contraction is initiated by H-atom abstraction at C-6 (hydrogen in light blue) of the substrate, and product is formed by stereoselective proton abstraction from a putative gem-aminocarboxylate intermediate. Lower inserts show active sites from the structures of CPH4 (PDB:4NJI), 6-CP (PDB:4NJG), and CDG (PDB: 4NJK) bound near the [4Fe-4S] of CDG synthase. The structure below the gem-aminocarboxylate intermediate is a model based on how CDG binds to CDG synthase. Glu 116 is also shown in this panel. Colors for the structures: Fe in rust, S in yellow, C in green, N in blue, O in red, and modeled H in white. The 7-proS and 7-proR hydrogens are shown in black and red spheres, respectively.
Figure 7
Figure 7
CPH4, CDG and 6-CP are all bound in the same manner with respect to the SAM-bound [4Fe-4S] cluster in the active site of CDG synthase. Color of the FeS cluster and SAM are as described as in Fig. 6.
Figure 8
Figure 8
Magnesium divalent cation (orange sphere) serves as a major binding determinant for CPH4 in the active site of CDG synthase. The substrate makes three contacts to the Mg2+. A Thr sidechain from the protein is also a ligand. The C-terminal carboxylate and Arg27 are also involved in binding the substrate. Colors are as described in Fig. 6 with the hydrogen that is abstracted (white) modeled into the structure.

Similar articles

Cited by

References

    1. McCarty RM, Bandarian V. Biosynthesis of pyrrolopyrimidines. Bioorg. Chem. 2012;43:15–25. - PMC - PubMed
    1. Nishimura H, Katagiri K, Sato K, Mayama M, Shimoka N. Toyocamycin, a new anti-candida antibiotics. The Journal of antibiotics. 1956;9:60–62. - PubMed
    1. RajBhandary U, Chang HJ, Gross F, Harada F, Kimura S, Nishimura S. E. coli tyrosine transfer RNA-primary sequence and direct evidence for base pairing between terminal sequences. Fed Proc Fed Amer Soc Exp Biol. 1969;28:409.
    1. Harada F, Nishimura S. Possible anticodon sequences of tRNA His , tRNA Asn , and tRNA Asp from Escherichia coli B. Universal presence of nucleoside Q in the first postion of the anticondons of these transfer ribonucleic acids. Biochemistry. 1972;11:301–8. - PubMed
    1. Kasai H, Oashi Z, Harada F, Nishimura S, Oppenheimer NJ, Crain PF, Liehr JG, von Minden DL, McCloskey JA. Structure of the modified nucleoside Q isolated from Escherichia coli transfer ribonucleic acid. 7-(4,5-cis-Dihydroxy-1-cyclopenten-3-ylaminomethyl)-7-deazaguanosine. Biochemistry. 1975;14:4198–208. - PubMed

Publication types

LinkOut - more resources